[Other] Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

Meghanamgowda Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-14 18:04
Reward10points

DOI: 10.1016/S1470-2045(13)70093-7

Title: Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

Please post full text with supplementary material
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    240


Return to the list